Therapeutic Drug Monitoring of Beta-lactams and Renal Hyperclearance in Patients Admitted to Intensive Care for Acute Brain Injury
Conditions
Critical Illness · Brain Injuries
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes, France
Contact: Study coordinator (Claire ROGER, MD, PhD)Contact: Principal Investigator (Claire ROGER, MD, PhD)